Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ZOPPO G")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

The neurovascular unit in the setting of strokeDEL ZOPPO, G. J.Journal of internal medicine. 2010, Vol 267, Num 2, pp 156-171, issn 0954-6820, 16 p.Conference Paper

Why do all drugs work in animals but none in stroke patients ? I: Drugs promoting cerebral blood flow : Stroke therapy : time for a clinical breakthroughDEL ZOPPO, G. J.Journal of internal medicine. 1995, Vol 237, Num 1, pp 79-88, issn 0954-6820Article

An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke : a progress reportDEL ZOPPO, G. J.Stroke (1970). 1990, Vol 21, Num 12, pp IV174-IV175, issn 0039-2499, SUPConference Paper

Relevance of focal cerebral ischemia models : experience with fibrinolytic agentsDEL ZOPPO, G. J.Stroke (1970). 1990, Vol 21, Num 12, pp IV155-IV160, issn 0039-2499, SUPConference Paper

Antiplatelet therapy in thrombotic thrombocytopenic purpuraDEL ZOPPO, G. J.Seminars in hematology. 1987, Vol 24, Num 2, pp 130-139, issn 0037-1963Article

INFLAMMATION AND THE NEUROVASCULAR UNIT IN THE SETTING OF FOCAL CEREBRAL ISCHEMIA : Brain-Immune Interactions in Acute and Chronic Brain DisordersDEL ZOPPO, G. J.Neuroscience. 2009, Vol 158, Num 3, pp 972-982, issn 0306-4522, 11 p.Article

Advances in the vascular pathophysiology of ischemic strokeDEL ZOPPO, G. J; HALLENBECK, J. M.Thrombosis research. 2000, Vol 98, Num 3, pp V73-V81, issn 0049-3848Article

Antithrombotic treatments in acute ischemic strokeDEL ZOPPO, G. J.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 938-946, issn 0340-6245Article

Localization of tissue plasminogen activator in the endothelium of a limited number of vesselsLEVIN, E. G; DEL ZOPPO, G. J.The American journal of pathology. 1994, Vol 144, Num 5, pp 855-861, issn 0002-9440Article

Clinical trials in acute stroke : Why have they not been successful?DEL ZOPPO, G. J.Neurology. 1998, Vol 51, Num 3, pp S59-S61, issn 0028-3878, SUP3Article

Trends and future developments in the pharmacological treatment of acute ischaemic strokeDEL ZOPPO, G. J; WAGNER, S; TAGAYA, M et al.Drugs (Basel). 1997, Vol 54, Num 1, pp 9-38, issn 0012-6667Article

The role of platelets in ischemic strokeDEL ZOPPO, G. J.Neurology. 1998, Vol 51, Num 3, pp S9-S14, issn 0028-3878, SUP3Article

Antithrombotic therapy of acute stroke : Thrombolytic agentsDEL ZOPPO, G. J.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 183-190, issn 0340-6245Conference Paper

Thrombolytic agents in the treatment of strokePESSIN, M. S; DEL ZOPPO, G. J; ESTOL, C. J et al.Clinical neuropharmacology. 1990, Vol 13, Num 4, pp 271-289, issn 0362-5664, 19 p.Article

Ischaemic damage of brain microvessels : inherent risks for thrombolytic treatment in strokeDEL ZOPPO, G. J; VON KUMMER, R; HAMANN, G. F et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 65, Num 1, pp 1-9, issn 0022-3050Article

Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. CommentaryHAMANN, G. F; OKADA, Y; FITRIDGE, R et al.Stroke (1970). 1995, Vol 26, Num 11, pp 2120-2126, issn 0039-2499Article

Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artry thrombosis model. Editorial commentUMEMURA, K; WADA, K; UEMATSU, T et al.Stroke (1970). 1993, Vol 24, Num 7, pp 1077-1082, issn 0039-2499Article

Distribution of integrin-like immunoreactivity on primate brain microvasculatureHARING, H.-P; AKAMINE, P; HABERMANN, R et al.Journal of neuropathology and experimental neurology. 1996, Vol 55, Num 2, pp 236-245, issn 0022-3069Article

Restricted endothelial cell expression of gravin in vivoGROVE, B. D; BOWDITCH, R; GORDON, T et al.The Anatomical record. 1994, Vol 239, Num 3, pp 231-242, issn 0003-276XArticle

Uptake of C5a by polymorphonuclear leukocytes (PMNs) after focal cerebral ischemia. I: Effect of tirilazad mesylate intervention on C5a uptake by PMNsHETLAND, G; DEL ZOPPO, G. J; MORI, E et al.Immunopharmacology (New York). 1994, Vol 27, Num 3, pp 191-198, issn 0162-3109Article

Carotid endarterectomy: factors influencing perioperative complicationsBRUCKMANN, H; DEL ZOPPO, G. J; FERBERT, A et al.Journal of neurology. 1987, Vol 235, Num 1, pp 39-41, issn 0340-5354Article

Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in Moyamoya disease. Editorial commentMASUDA, J; OGATA, J; YUTANI, C et al.Stroke (1970). 1993, Vol 24, Num 12, pp 1960-1967, issn 0039-2499Article

Matrix metalloproteinases increase very early during experimental focal cerebral ischemiaJI HOE HEO; LUCERO, J; ABUMIYA, T et al.Journal of cerebral blood flow and metabolism. 1999, Vol 19, Num 6, pp 624-633, issn 0271-678XArticle

Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. CommentaryWANG, X; BARONE, F. C; AIYAR, N. V et al.Stroke (1970). 1997, Vol 28, Num 1, pp 155-162, issn 0039-2499Conference Paper

Thrombolytic therapy in the treatment of stroke. DiscussionDEL ZOPPO, G. J; LEVY, D; BRODERICK, J. P et al.Drugs (Basel). 1997, Vol 54, pp 90-99, issn 0012-6667, SUP3Conference Paper

  • Page / 3